The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References

Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below. 

23 – Mahesh K. Kaushik et al., PLoS One 12, no. 2, e0172508, February 2017

Triethylene Glycol, an Active Component of Ashwagandha (Withania Somnifera) Leaves, is Responsible for Sleep Induction

24 – Dnyanraj Choudhary et al., Journal of Dietary Supplements 14, no. 6, 1–14, February 2017

Efficacy and Safety of Ashwagandha (Withania Somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions

25 – Kaustubh S. Chaudhari et al., Annals of Neurosciences 24, no. 2, 111–22, May 2017

Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer’s Disease

25 – Grace McPhee, Luke Andrew Downey, and Con K. Stough, Medical Hypotheses 95, 71–76, October 2016

Cognitive Training and Bacopa Monnieri: Evidence for a Combined Intervention to Alleviate Age Associated Cognitive Decline

26 – Anne Caufriez et al., The Journal of Clinical Endocrinology and Metabolism 96, no. 4, E614–23, February 2011

Progesterone Prevents Sleep Disturbances and Modulates GH, TSH, and Melatonin Secretion in Postmenopausal Women

27 – Pronob K. Dalal and Manu Agarwal, Indian Journal of Psychiatry 57, supplement 2, S222–32, July 2015

Postmenopausal Syndrome

28 – Erin S. LeBlanc et al., JAMA 285, no. 11, 1489–99, April 2001

Hormone Replacement Therapy and Cognition: Systematic Review and Meta-Analysis

29 – Riley Bove et al., Neurology 82, no. 3, 222–29, January 2014

Age at Surgical Menopause Influences Cognitive Decline and Alzheimer Pathology in Older Women

30 – Whitney Wharton, et al., American Journal of Translational Research 1, no. 2, 131–47, January 2009

Potential Role of Estrogen in the Pathobiology and Prevention of Alzheimer’s Disease

31 – Rowan T. Chlebowski et al., JAMA Oncology 1, no. 3, 296–305, June 2015

Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women’s Health Initiative Randomized Clinical Trials